Old Web
English
Sign In
Acemap
>
authorDetail
>
Hua Yin
Hua Yin
Huazhong University of Science and Technology
Myeloid leukemia
Medicine
Internal medicine
Leukemia
Imatinib
5
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
RNA methylation in hematological malignancies and its interactions with other epigenetic modifications.
2021
Leukemia
Lan Yao
Hua Yin
Mei Hong
Yajun Wang
Tingting Yu
Yao Teng
Tingting Li
Qiuling Wu
Show All
Source
Cite
Save
Citations (0)
[Prognostic significance of early molecular response after second-line treatment with dasatinib of chronic myeloid leukemia patients].
2019
Chinese Journal of Hematology
Yilin Chen
Li Meng
Guolin Yan
Zhuangzhi Yang
Zhiping Huang
Youshan Zhang
Zhe Zhao
Chucheng Wang
Ying Bao
Hang Xiang
Hua Yin
Lifeng Chen
Yingyuan Xiong
Long Wang
Weiming Li
Show All
Source
Cite
Save
Citations (0)
Feasibility study on treatment of switching to nilotinib after first-line imatinib in the chronic phase of chronic myeloid leukemia
2019
Clinical Lymphoma, Myeloma & Leukemia
Yilin Chen
Hua Yin
Lifeng Chen
Yingyuan Xiong
Li Meng
Jingming Guo
Haiyan Wang
Weiming Li
Show All
Source
Cite
Save
Citations (0)
[Efficacy and safety of domestic dasatinib as second-line treatment for chronic myeloid leukemia patients in the chronic phase].
2019
Chinese Journal of Hematology
Yilin Chen
Long Wang
Guolin Yan
Zhuangzhi Yang
Zhiping Huang
Youshan Zhang
Zhe Zhao
Chucheng Wan
Ying Bao
Hang Xiang
Hua Yin
Lifeng Chen
Yingyuan Xiong
Li Meng
Weiming Li
Show All
Source
Cite
Save
Citations (1)
The clinical analysis of frontline nilotinib vs imatinib therapies for newly diagnosed chronic myeloid leukemia in chronic phase
2017
Chinese Journal of Internal Medicine
Hua Yin
L.F. Chen
J. K. Cui
Y. Y. Xiong
Y You
Ping Zou
Weiming Li
Show All
Source
Cite
Save
Citations (0)
1